Cantor Fitzgerald initiated coverage of United Therapeutics (UTHR) with an Overweight rating and $405 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTHR:
- Maintaining Market Position: United Therapeutics’ Tyvaso DPI Amidst Competition and Future Growth Prospects
- Liquidia price target raised to $23 from $20 at Wells Fargo
- Hold Rating for United Therapeutics Amid Competitive Pressures from LQDA’s Yutrepia
- Liquidia price target raised to $37 from $29 at BTIG
- Liquidia price target raised to $31 from $27 at Jefferies
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue